SEARCH RESULTS FOR: "Tag: IMGN"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2023(2)
2019(1)
2018(3)
2017(4)
2015(6)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(1)
Analyst Upgrades(2)
By the Numbers(1)
Editor's Pick(1)
Ezines(1)
General(1)
Intraday Option Activity(1)
Market Recap(1)
Midday Market Check(2)
Quantitative Analysis(3)
Stocks On the Move(2)
Technical Analysis(3)
Trade Postmortem(1)

8/8/2023 3:11 PM
Subscribers to Schaeffer's Event Trader service scored a 272% profit with our ImmunoGen, Inc. (NASDAQ:IMGN) August 17 put recommendation. Below, we will take a closer look at why IMGN was on our ra...
6/23/2023 8:49 AM
Subscribers to Chart of the Week received this commentary on Sunday, June 18. The biotech sector comes with a large ‘buyer beware’ sticker. Most stocks in the sector are prone to volatile moves depen...
3/1/2019 12:04 PM
A tame reading on the Fed-watched personal consumption expenditures (PCE) index and hopes for a U.S.-China trade deal have markets cautiously higher this afternoon. However, lackluster data on U...
7/25/2018 2:13 PM
Two biotech names to watch in the next month are Array Biopharma Inc (NASDAQ:ARRY) and ImmunoGen, Inc. (NASDAQ:IMGN). Both stocks have struggled recently, but could both be poised to snap out of the...
4/13/2018 2:42 PM
ImmunoGen, Inc. (NASDAQ:IMGN) is struggling today, down 2.3% to trade at $10.24. The biotech stock raced to a two-year high of $13.41 on March 26, but promptly pulled back in the past two weeks. If hi...